show less
show more
@colonpanda3
About paclitaxel therapy, RACK1, DLC1, along with CIS mediated your destruction regarding BimEL through the ElonginB/C-Cullin2-CIS ubiquitin-protein isopeptide ligase complex. Many of us even more indicated that RACK1 conferred paclitaxel resistance to breast cancers cells inside vitro as well as in vivo. Finally, many of us witnessed the […] View